NCT07491705

Brief Summary

Study title Camel Milk Impact on Aerobic Exercise Recovery, Induced Inflammation, and Physical Performance Investigator Dr. Mo'ath Bataineh Department of Nutrition and Health College of Medicine \& Health Sciences United Arab Emirates University Brief Summary This study aims to examine the effects of post-exercise camel milk consumption on recovery and subsequent high-intensity cycling performance in recreationally trained adult males. The primary objective is to determine whether camel milk improves time to exhaustion and overall workload compared with cow's milk or water. Secondary objectives include assessing its impact on muscle soreness, muscle damage, and inflammatory markers following intense exercise. Participants are healthy, non-obese males over 18 years of age with no milk allergies and not using antioxidant supplements, anti-inflammatory drugs, or antibiotics. A total of 12 individuals will be enrolled. The study involves four laboratory visits. The first includes an educational workshop on recording diet and exercise, development of an individualized standardized diet, and baseline assessments of body measurements and aerobic performance (peak work rate, heart rate, maximum speed at exhaustion, and VO₂max). The remaining three visits occur 4-5 days apart. In each session, resting physiological measures are recorded, followed by a cycling exercise. Participants then consume the assigned experimental beverage and rest for 210 minutes before completing a second cycling test. Four blood samples are collected per visit at designated time points. Participation is voluntary, and individuals may withdraw at any time. There are no anticipated risks beyond potential discomfort from some questions or procedures. Although participants may not receive direct personal benefit, the findings may contribute to improved understanding of exercise recovery strategies. All collected information will remain confidential, with identifying data stored securely and not included in any publications. Study results will be disseminated through peer-reviewed journals, conferences, and required reports to UAEU's Human Research Ethics Committee and the Research Office. The project is conducted and funded by United Arab Emirates University and has received ethical approval by UAEU Human Ethics Committee on February 7, 2024, (ERH\_2023\_3935).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Apr 2024

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 11, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 24, 2026

Completed
Last Updated

March 24, 2026

Status Verified

March 1, 2026

Enrollment Period

1.1 years

First QC Date

March 11, 2026

Last Update Submit

March 18, 2026

Conditions

Keywords

MilkExerciseRecoveryInduced InflammationPhysical Performance

Outcome Measures

Primary Outcomes (2)

  • Time to Exhaustion (minutes)

    Duration of the cycling-to-exhaustion test recorded in minutes

    From enrollment to the end of treatment at 6 hours

  • Exercise Capacity (workload in watts)

    Maximum workload achieved during the post recovery exercise capacity test

    From enrollment to the end of treatment at 6 hours

Secondary Outcomes (6)

  • Heart Rate (beats per minute)

    From enrollment to the end of treatment at 6 hours

  • Rating of Perceived Exertion (RPE units)

    From enrollment to the end of treatment at 6 hours

  • Oxygen Consumption (VO₂; mL·kg-¹·min-¹)

    From enrollment to the end of treatment at 6 hours

  • Carbon Dioxide Production (VCO₂; mL·kg-¹·min-¹)

    From enrollment to the end of treatment at 6 hours

  • Plasma Cytokines (pg/mL)

    From enrollment to the end of treatment at 6 hours

  • +1 more secondary outcomes

Study Arms (3)

Control

OTHER

No treatment

Other: Control

Camel Milk

EXPERIMENTAL

Received camel milk

Dietary Supplement: Camel Milk

Cow Milk

EXPERIMENTAL

Received cow milk

Dietary Supplement: Cow Milk

Interventions

ControlOTHER

Twelve recreationally trained healthy male participants will be recruited to perform three cycling to volitional exhaustion trials followed by 4-hour recovery period and a subsequent exercise capacity test. Following conclusion of the cycling exercise session and within a period of 30 minutes at the start of the recovery period from the cycling exercise, an equal 500 ml volume of either water, cow milk, or camel milk will be consumed in a crossover counterbalanced design. Time to exhaustion, heart rate (HR), rating of perceived exertion (RPE), oxygen consumption, carbon dioxide production, and workload will be recorded per trial. Blood samples will be collected before and after exercise to determine plasma levels of systemic cytokines (IL-6, IL-10, TNF-α) and creatine kinase (CK).

Control
Camel MilkDIETARY_SUPPLEMENT

Twelve recreationally trained healthy male participants will be recruited to perform three cycling to volitional exhaustion trials followed by 4-hour recovery period and a subsequent exercise capacity test. Following conclusion of the cycling exercise session and within a period of 30 minutes at the start of the recovery period from the cycling exercise, an equal 500 ml volume of either water, cow milk, or camel milk will be consumed in a crossover counterbalanced design. Time to exhaustion, heart rate (HR), rating of perceived exertion (RPE), oxygen consumption, carbon dioxide production, and workload will be recorded per trial. Blood samples will be collected before and after exercise to determine plasma levels of systemic cytokines (IL-6, IL-10, TNF-α) and creatine kinase (CK).

Camel Milk
Cow MilkDIETARY_SUPPLEMENT

Twelve recreationally trained healthy male participants will be recruited to perform three cycling to volitional exhaustion trials followed by 4-hour recovery period and a subsequent exercise capacity test. Following conclusion of the cycling exercise session and within a period of 30 minutes at the start of the recovery period from the cycling exercise, an equal 500 ml volume of either water, cow milk, or camel milk will be consumed in a crossover counterbalanced design. Time to exhaustion, heart rate (HR), rating of perceived exertion (RPE), oxygen consumption, carbon dioxide production, and workload will be recorded per trial. Blood samples will be collected before and after exercise to determine plasma levels of systemic cytokines (IL-6, IL-10, TNF-α) and creatine kinase (CK).

Cow Milk

Eligibility Criteria

Age18 Years - 39 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Recreational athlete
  • Active 5 Days a Week
  • Male
  • Healthy
  • Non-Obese
  • to 30 years old
  • No allergies to milk.

You may not qualify if:

  • Sedentary
  • Female
  • Allergies to milk
  • Presence of diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

United Arab Emirates University Building E3 Room 0015

Al Ain City, Abu Dhabi Emirate, 15551, United Arab Emirates

Location

MeSH Terms

Conditions

Motor Activity

Interventions

Milk

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

BeveragesDiet, Food, and NutritionPhysiological PhenomenaDairy ProductsFoodFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 11, 2026

First Posted

March 24, 2026

Study Start

April 30, 2024

Primary Completion

May 30, 2025

Study Completion

June 1, 2025

Last Updated

March 24, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

To maintain the privacy of the individuals

Locations